- Home
- ICAD
ICAD
iCAD Inc.
as 11-15-2024 4:00pm EST
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | NASHUA |
| Market Cap: | 40.8M | IPO Year: | 1986 |
| Target Price: | N/A | AVG Volume (30 days): | 257.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.10 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.18 - $2.65 | Next Earning Date: | 11-13-2024 |
| Revenue: | $18,940,000 | Revenue Growth: | 10.03% |
| Revenue Growth (this year): | 13.15% | Revenue Growth (next year): | 24.28% |
Latest iCAD Inc. News
ICAD Breaking Stock News: Dive into ICAD Ticker-Specific Updates for Smart Investing
Simply Wall St.
a day ago
iCAD Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Thomson Reuters StreetEvents
3 days ago
Q3 2024 ICAD Inc Earnings Call
Associated Press Finance
4 days ago
Icad: Q3 Earnings Snapshot
GlobeNewswire
4 days ago
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024
GlobeNewswire
5 days ago
iCAD's ProFound Detection Version 4.0 Gains FDA Clearance
GlobeNewswire
11 days ago
iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference
GlobeNewswire
12 days ago
iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024
Insider Monkey
24 days ago
ICAD, Inc. (ICAD): A Bull Case Theory
Compare ICAD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ICAD iCAD Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.